Immuron (IMRN) Assets Average (2016 - 2025)
Immuron's quarterly Assets Average came in at $3.3 million in Q3 2025, down 36.67% year-on-year from $5.2 million in Q3 2024, and down 54.39% quarter-over-quarter from $7.2 million in Q2 2025.
Immuron has reported Assets Average for 10 years, with the latest figure at $3.3 million in Q3 2025.
- For the quarter ending Q3 2025, Assets Average fell 36.67% year-over-year to $3.3 million; the trailing twelve-month figure through Sep 2025 stood at $3.3 million (down 36.67% YoY), and the FY2025 full-year result was $3.3 million, down 35.61% from the prior year.
- Assets Average for Q3 2025 stood at $3.3 million, down from $7.2 million in the prior quarter.
- The five-year high for Assets Average was $20.4 million in Q3 2023, with the low at $3.3 million in Q3 2025.
- Average Assets Average over 5 years is $11.3 million, with a median of $10.0 million recorded in 2021.
- Year-over-year, Assets Average jumped 444.7% in 2021 and sank 74.52% in 2024.
- Tracing IMRN's Assets Average over 5 years: stood at $16.5 million in 2021, then grew by 2.04% to $16.8 million in 2022, then tumbled by 56.74% to $7.3 million in 2023, then slumped by 44.2% to $4.1 million in 2024, then retreated by 18.8% to $3.3 million in 2025.
- The last three Assets Average figures came in at $3.3 million (Q3 2025), $7.2 million (Q2 2025), and $4.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 3.29 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 9, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Dec 31, 2023 | 7.27 Mn |
| Sep 28, 2023 | 20.27 Mn |
| Aug 30, 2023 | 20.41 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Dec 31, 2022 | 16.81 Mn |
| Aug 31, 2022 | 8.77 Mn |
| Jun 30, 2022 | 16.46 Mn |
| Dec 31, 2021 | 16.47 Mn |
| Jun 30, 2021 | 11.24 Mn |
| Dec 31, 2020 | 25.48 Mn |
| Sep 1, 2020 | 16.40 Mn |
| Jun 30, 2020 | 2.06 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Jun 30, 2019 | 6.85 Mn |
| Dec 31, 2018 | 19.26 Mn |
| Jun 30, 2018 | 5.90 Mn |
| Jun 30, 2017 | 6.44 Mn |
| Dec 31, 2016 | 6.62 Mn |